Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Research and Markets - Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) Report 2016 with Profiles of MilliporeSigma, Horizon Discovery Group, OriGene, ThermoFisher Scientific, and ToolGen.

This image opens in the lightbox

News provided by

Research and Markets

17 Oct, 2016, 11:51 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, October 17, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other)" report to their offering.

Genome editing is the process of modifying the DNA of a particular organism, by introducing breaks at specific, targeted locations in the genome. At the present time, ZFNs, TALENs and CRISPR-Cas9 are the most used and commercially developed technologies.

The report provides revenues and forecasts by technology, including: global revenues and forecast for the CRISPR-based market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market); global revenues and forecast for the ZFN market by type of product, 2014-2020 (reagents & tools, Research services, Edited cell lines, Edited animal models, Total Market); global revenues and forecast for the TALEN market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market); and global revenues and forecast for other gene editing technologies market by type of product, 2014-2020 (reagents & tools, research services, edited cell lines, edited animal models, total market).

The competition has increased in recent years among the companies active in this market, particularly in the CRISPR/Cas9 segment, as new products have been developed and introduced to market. In 2016, multiple players participate in this market, from large multinational corporations to small, niche life sciences companies. These companies develop and commercialize various products and services for each of the major gene editing technologies.

Companies profiled in the report include include MilliporeSigma, Horizon Discovery Group, OriGene, ThermoFisher Scientific, and ToolGen.

Gene editing technologies have a multitude of commercial applications in numerous fields, such as the development of human therapeutics, new varieties of plants, new breeds of animals, improved animal models for research, and novel sources of chemicals and energy. Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) provides detailed descriptions of these applications.

Key Topics Covered:

1: Executive Summary

  • Overview of Gene Editing
  • Commercial Applications of Gene Editing Technologies
  • Selected Commercial Gene Editing Products
  • Industry Structure
  • Market Trends
  • Total Market Revenues and Forecast

2: Introduction and Applications of Gene Editing Technologies

  • Overview of Gene Editing
  • Current Major Genome Editing Technologies
  • Commercial Applications of Gene Editing Technologies
  • Human Therapeutics
  • Plant Engineering
  • Animal Breeding/Research Models

3: Gene Editing Technologies

  • Zinc Finger Nucleases (ZFNs)
  • Transcription Activator-Like Effector Nucleases (TALENs)
  • Selected TALEN Gene Editing Products and Technologies
  • CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9
  • Advantages and Limitations of CRISPR-Cas9 Technology
  • Selected CRISPR-Cas9 Gene Editing Products
  • Other Gene Editing Technologies
  • Meganucleases
  • The rAAV Technology

4: Industry Structure

  • Tiers of Competition
  • Barriers to Entry
  • Competitive Factors
  • Notable Mergers and Acquisitions
  • Regulatory Aspects of Genetic Editing
  • Market Trends
  • Increasing Development of Therapeutics Using Gene Editing Technologies to
  • Augment Market Revenues
  • Intensified R&D Activity in Non-medical Fields to Accelerate Market Growth
  • Increasing Investments and Funding in Gene Editing Area to Augment Market
  • Revenues
  • Growing Awareness about Gene Editing Technologies among Researchers to Spur
  • Utilization of Gene Editing Technologies
  • Limitations of Available Technologies to Constrain Market Growth
  • Ethical Considerations to Restrain Utilization and Market Growth
  • Regulatory Constraints to Impede Market Expansion
  • Patent Disputes to Slow Market Growth

5: Total Market Revenues and Forecast

  • Market Snapshot
  • Total Market Forecast
  • Market Revenues and Forecast by Technology
  • Zinc Finger Nuclease (ZFN) Technologies
  • TALEN Technologies
  • CRISPR-based Technologies
  • Other Gene Editing Technologies

6: Company Profiles

  • Agilent Technologies, Inc.
  • Allele Biotechnology
  • Applied Biological Materials, Inc.
  • Applied StemCell Inc.
  • Caribou Biosciences, Inc.
  • Cellectis, Inc.
  • CRISPR Therapeutics AG
  • Dharmacon
  • DNA2.0, Inc.
  • Editas Medicine
  • GeneCopoeia
  • GenScript
  • Horizon Discovery Group, Plc
  • Integrated DNA Technologies
  • Intellia Therapeutics
  • MilliporeSigma
  • ZFN Products
  • CRISPR/Cas9 Genome Editing Tools
  • OriGene Technologies, Inc.
  • PNA Bio, Inc.
  • Precision BioSciences
  • Sangamo Biosciences, Inc.
  • Santa Cruz Biotechnology, Inc.
  • System BioSciences
  • Takara Bio USA (Clontech Laboratories)
  • ThermoFisher Scientific
  • TALEN Products
  • CRISPR Products
  • GeneArt Engineered Cell Models
  • ToolGen, Inc.
  • Transposagen, Inc.
  • CRISPR-Cas9 Products
  • XTN TALEN Products
  • TriLink Biotechnology For more information about this report visit http://www.researchandmarkets.com/research/wnrkpn/gene_editing

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.